Member of the Association of American Physicians
James K. Liao mostly deals with Internal medicine, Endocrinology, Pharmacology, Cell biology and Nitric oxide. The Internal medicine study combines topics in areas such as Intracellular, Superoxide and Bioinformatics. Endocrinology is closely attributed to Protein kinase B in his research.
His studies in Pharmacology integrate themes in fields like Inflammation, Reductase, Cholesterol and Enzyme inhibitor. His Cell biology research is multidisciplinary, relying on both Endothelial stem cell and Angiogenesis. His studies deal with areas such as Tumor necrosis factor alpha, Molecular biology and Endothelium as well as Nitric oxide.
The scientist’s investigation covers issues in Internal medicine, Endocrinology, Cell biology, Pharmacology and Cardiology. James K. Liao has researched Internal medicine in several fields, including Kinase and Rho-associated protein kinase. In his study, PI3K/AKT/mTOR pathway is inextricably linked to Protein kinase B, which falls within the broad field of Endocrinology.
His biological study spans a wide range of topics, including Endothelial stem cell and Biochemistry. His work carried out in the field of Pharmacology brings together such families of science as Inflammation, Downregulation and upregulation, Ischemia and HMG-CoA reductase. His work focuses on many connections between Cholesterol and other disciplines, such as Statin, that overlap with his field of interest in Pleiotropy.
James K. Liao mainly investigates Internal medicine, Cardiology, Endocrinology, Heart failure and Emergency medicine. Internal medicine and Oncology are frequently intertwined in his study. His research investigates the connection between Cardiology and topics such as Stroke that intersect with problems in Platelet and Ischemia.
James K. Liao combines subjects such as Actin cytoskeleton and Rho-associated protein kinase with his study of Endocrinology. His Rho-associated protein kinase study also includes
His main research concerns Internal medicine, Endocrinology, Rho-associated protein kinase, Actin cytoskeleton and Stroke. His research integrates issues of Placebo, Fasudil and Cardiology in his study of Internal medicine. His study in Endocrinology concentrates on Cholesterol, Diastole and Angiotensin II.
James K. Liao has included themes like Statin and Lesion in his Rho-associated protein kinase study. His Lesion research incorporates elements of Simvastatin, Pharmacology and Disease. His Stroke research is multidisciplinary, incorporating elements of Pleiotropy, Nicotinamide adenine dinucleotide phosphate, Platelet, Tissue plasminogen activator and Morris water navigation task.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Upregulation of Endothelial Nitric Oxide Synthase by HMG CoA Reductase Inhibitors
U. Laufs;V. La Fata;J. Plutzky;J. K. Liao.
Circulation (1998)
PLEIOTROPIC EFFECTS OF STATINS
James K. Liao;Ulrich Laufs.
Annual Review of Pharmacology and Toxicology (2005)
Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines.
R De Caterina;Peter Libby;H B Peng;V J Thannickal.
Journal of Clinical Investigation (1995)
Pleiotropic Effects of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors
Masao Takemoto;James K. Liao.
Arteriosclerosis, Thrombosis, and Vascular Biology (2001)
Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase
Tommaso Simoncini;Ali Hafezi-Moghadam;Derek P. Brazil;Klaus Ley.
Nature (2000)
Post-transcriptional Regulation of Endothelial Nitric Oxide Synthase mRNA Stability by Rho GTPase
Ulrich Laufs;James K. Liao.
Journal of Biological Chemistry (1998)
Anti-inflammatory Properties of Cytochrome P450 Epoxygenase-Derived Eicosanoids
Koichi Node;Yuqing Huo;Xiulu Ruan;Baichun Yang.
Science (1999)
Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase
Matthias Endres;Ulrich Laufs;Zhihong Huang;Tadashi Nakamura.
Proceedings of the National Academy of Sciences of the United States of America (1998)
Induction and Stabilization of IκBα by Nitric Oxide Mediates Inhibition of NF-κB
Hai-Bing Peng;Peter Libby;James K. Liao.
Journal of Biological Chemistry (1995)
OXIDIZED LOW-DENSITY LIPOPROTEIN DECREASES THE EXPRESSION OF ENDOTHELIAL NITRIC OXIDE SYNTHASE
James K. Liao;Wee Soo Shin;Wen Yee Lee;Stephen L. Clark.
Journal of Biological Chemistry (1995)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Harvard University
Saarland University
Hiroshima University
Hiroshima University
Brigham and Women's Hospital
National Institutes of Health
Harvard University
University of Chicago
Charité - University Medicine Berlin
Harvard Medical School
Business International Corporation
University of Edinburgh
Pacific Northwest National Laboratory
The University of Texas at Austin
Kettering University
Tel Aviv University
Chinese Academy of Sciences
University of Paris-Saclay
Nara Women's University
MRC Cognition and Brain Sciences Unit
La Trobe University
University of Connecticut
University of Amsterdam
University of Groningen
Cleveland Clinic
Duke University